These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10418031)

  • 1. [Susceptibility of Clostridium difficile to metronidazole using the E-test: effect of the culture medium].
    Poilane I; Cruaud P; Rousseau JG; Torlotin JC; Collignon A
    Pathol Biol (Paris); 1999 May; 47(5):515-8. PubMed ID: 10418031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility of genotypically distinct and clonal Clostridium difficile strains to oritavancin.
    O'Connor R; Baines SD; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2008 Oct; 62(4):762-5. PubMed ID: 18606787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of reduced susceptibility to metronidazole in Clostridium difficile.
    Baines SD; O'Connor R; Freeman J; Fawley WN; Harmanus C; Mastrantonio P; Kuijper EJ; Wilcox MH
    J Antimicrob Chemother; 2008 Nov; 62(5):1046-52. PubMed ID: 18693234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological study of Clostridium difficile strains isolated in Jean-Verdier-René-Muret hospitals from 2001 to 2007].
    Poilane I; Fantinato C; Cruaud P; Collignon A
    Pathol Biol (Paris); 2008; 56(7-8):412-6. PubMed ID: 18842360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of metronidazole susceptibility in different Clostridium difficile PCR ribotypes.
    Moura I; Spigaglia P; Barbanti F; Mastrantonio P
    J Antimicrob Chemother; 2013 Feb; 68(2):362-5. PubMed ID: 23104495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of the disk diffusion method for screening Clostridium difficile isolates with decreased susceptibility to antibiotics].
    Poilane I; Bert F; Cruaud P; Nicolas-Chanoine MH; Collignon A
    Pathol Biol (Paris); 2007 Nov; 55(8-9):429-33. PubMed ID: 17905536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
    Pituch H; Obuch-Woszczatyński P; Glinka D; Łazińska B; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2003; 55(3):253-8. PubMed ID: 14702667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimicrobial susceptibility of Clostridium difficile clinical isolates collected from 2001 to 2007 in a French university hospital].
    Cattoir V; Ould-Hocine ZF; Legrand P
    Pathol Biol (Paris); 2008; 56(7-8):407-11. PubMed ID: 18845403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of Clostridium difficile isolates from horses in an intensive care unit and association of disease severity with strain type.
    Magdesian KG; Dujowich M; Madigan JE; Hansen LM; Hirsh DC; Jang SS
    J Am Vet Med Assoc; 2006 Mar; 228(5):751-5. PubMed ID: 16506942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of Clostridium difficile by E test.
    Cheng SH; Chu FY; Lo SH; Lu JJ
    J Microbiol Immunol Infect; 1999 Jun; 32(2):116-20. PubMed ID: 11561576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Helicobacter pylori to metronidazole.
    Perna F; Gatta L; Figura N; Ricci C; Tampieri A; Holton J; Miglioli M; Vaira D
    Am J Gastroenterol; 2003 Oct; 98(10):2157-61. PubMed ID: 14572561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronidazole resistance in Clostridium difficile.
    Johnson S; Sanchez JL; Gerding DN
    Clin Infect Dis; 2000 Aug; 31(2):625-6. PubMed ID: 10987742
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical experience with the detection Clostridium difficile].
    Chmelarová E; Skapová T
    Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):86-9. PubMed ID: 20640985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of supplemented Brucella agar and modified Clostridium difficile agar for antimicrobial susceptibility testing of Clostridium difficile.
    Kim GH; Kim J; Pai H; Kang JO
    Ann Lab Med; 2014 Nov; 34(6):439-45. PubMed ID: 25368819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of metronidazole and vancomycin in combination on Clostridium difficile.
    Hames A; Perry JD; Gould FK
    J Antimicrob Chemother; 2009 May; 63(5):1076. PubMed ID: 19240074
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of the Etest method for antimicrobial susceptibility testing of obligate anaerobes].
    Rokosz A; Sawicka-Grzelak A; Kot K; Meszaros J; Łuczak M
    Med Dosw Mikrobiol; 2001; 53(2):167-75. PubMed ID: 11757426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of teicoplanin against Clostridium difficile.
    Wongwanich S; Kusum M; Phan-Urai R
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):606-9. PubMed ID: 9185278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.
    Freeman J; Baines SD; Saxton K; Wilcox MH
    J Antimicrob Chemother; 2007 Jul; 60(1):83-91. PubMed ID: 17483547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic resistance of Clostridium difficile isolates.
    Dworczyński A; Sokół B; Meisel-Mikołajczyk F
    Cytobios; 1991; 65(262-263):149-53. PubMed ID: 1828756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates.
    Erikstrup LT; Danielsen TK; Hall V; Olsen KE; Kristensen B; Kahlmeter G; Fuursted K; Justesen US
    Clin Microbiol Infect; 2012 Aug; 18(8):E266-72. PubMed ID: 22672504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.